The new ninth edition of this well established publication has been completely expanded to include the latest concepts, various changes in approaches, up-to-date clinical information, recent clinical trials, and new antihypertensive drugs and drug delivery systems. New chapters cover Obesity as well as Hypertension and Diabetes Mellitus. The latest studies such as Hypertension Optimal Treatment (HOT), The Captopril Prevention Project (CAPPP), and the United Kingdom Prospective Diabetes Study (UKPDS) are also addresses. Features: * Covers the latest clinical research studies * New chapters include Obesity and Hypertension and Diabetes Mellitus * Provides excellent advice on individualised treatment programs * Handy pocket-size format provides easy access and convenience and an affordable price
The new ninth edition of this well established publication has been completely expanded to include the latest concepts, various changes in approaches, up-to-date clinical information, recent clinical trials, and new antihypertensive drugs and drug delivery systems. New chapters cover Obesity as well as Hypertension and Diabetes Mellitus. The latest studies such as Hypertension Optimal Treatment (HOT), The Captopril Prevention Project (CAPPP), and the United Kingdom Prospective Diabetes Study (UKPDS) are also addresses. Features: * Covers the latest clinical research studies * New chapters include Obesity and Hypertension and Diabetes Mellitus * Provides excellent advice on individualised treatment programs * Handy pocket-size format provides easy access and convenience and an affordable price
Auflage
Sprache
Verlagsort
Verlagsgruppe
Zielgruppe
Für die Erwachsenenbildung
Für höhere Schule und Studium
Editions-Typ
Illustrationen
Maße
Gewicht
ISBN-13
978-1-56053-322-1 (9781560533221)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Klassifikation
Hypothesis: Essential Hypertension and End-Organ Damage. Hypertension in the United States and Classification. Secondary Hypertension. Indirect Measurement of Blood Pressure. Korotkoff Sounds. Common Mistakes in Blood Pressure reading. Hypertensive-Atheroscelrotic Syndrome. Nonpharmacologic Treatment of Hypertension. Obesity. Approaches to Selection of Antihypertensive Therapy. Hemodynamics in Hypertension. Hemodynamics: Logical and Preferred Method to Reduce Blood Pressure. Hemodynamic Effects of Antihypertensive Drugs. Hypertension-Related End-Organ Damage. Life Expectancy and Blood Pressure. Effects of Treatment of Hypertension. Selected Controlled, Randomized Clinical Trials with Diuretics and Beta-Blockers in mild to moderate Hypertension and Coronary Heart Disease 1979-1992. Diuretic and Beta-Blocker Clinical Trials in Mild to Moderate Hypertension and Coronary Heart Disease: Summary. Clinical Hypertension Trials with Calcium Channel Blockers. Coronary Heart Disease: Risk Factors. Coronary Heart Disease: More Potential Risk Factors. Coronary Heart Disease Risk Factors: Influence of Diuretic and Beta-Blocker Therapy. Antihypertensive Drugs and Serum Lipids. Serum Lipids and Antihypertensive Therapy with Diuretics and Beta-Blockers: Summary. Effects of Antihypertensive Drugs on Coronary Heart Disease Risk Factors. Antihypertensive Drugs and Coronary Heart Disease Risk Factors: Summary. Calcium Channel blockers and atherosclerosis (Coronary Heart Disease Reduction). Hypertension and Renal Damage. Hypertension-Related Renal Damage: Postulated Mechanisms. Hypertension, Renal Disease and Antihypertensive Therapy. Effects of Antihypertensive Drugs on Renal Function. Hypertension and Diabetes Mellitus. Selection of Therapy Based on Subsets of Hypertension. Demographics and Antihypertensive Drugs. Hypertensive diabetics: Mortality and Coronary Heart dice and Antihypertensive Therapy. Resistant Hypertension. Hypertensive Urgencies and Emergencies. Hypertension in Pregnancy. Quality of Life and Antihypertensive Therapy (Selected Trials). Total Cost of Antihypertensive Therapy. Characteristics of the Ideal Antihypertensive Drug. Combination Antihypertensive Therapy: Selected Drugs. Combination Antihypertensive Therapy: Selected Drugs: Summary. Antihypertensive Therapy: Efficacy of Monotherapy. Selected Drug interactions with Antihypertensive Therapy. Maximum Recommended Doses of Antihypertensive Drugs with Best Treatment Characteristics. Diuretics. Diuretics Highlights. Central Alpha-Agonists. Central Alpha-Agonists: Similarities. Central Alpha-Agonists Highlights. Comparison of commonly Used Oral Central Alpha-Agonists. Postganglionic Neuron Inhibitors. Postganglionic Neuron Inhibitors Highlights. Beta-Blockers - General. Side Effects and Contraindications of Beta-Blockers. Drug Interactions with Beta-Blockers. Beta-Blockers Highlights. Direct Vasodilators. Direct Vasodilators Highlights. Alpha-Blockers. Alpha-Blockers Highlights. Angiotensin-Converting Enzyme (ACE) Inhibitors. ACE Inhibitors Highlights. Calcium Channel Blockers. Calcium Channel Blockers Highlights. Angiotensin II Receptor Blockers (ARBs). Ang-II Receptor Blockers (ARBs) Highlights. Selected Combination Antihypertensive Drugs. Hypertension Drug Selection: Summary. New Antihypertensive Drug Classes. Conclusions. Subset Selection of Antihypertensive Therapy. References.
